Press release
Migraine Treatment Market: Major Trends Reshaping the Future of the Industry
Migraine Treatment Market
What Will the Migraine Treatment Industry Market Size Be by 2025?
In recent times, the market for migraine treatments has been seeing robust growth. It is anticipated to expand from $3.18 billion in 2024 to $3.48 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.4%. The past growth in this market has been attributed to factors such as rises in incidences of migraine, augmented healthcare expenditure, enhancement in the formulations of existing medications, growth in clinical research, and the emergence of new treatment strategies.
What's the Long-Term Growth Forecast for the Migraine Treatment Market Size Through 2029?
The market for migraine treatment is predicted to expand rapidly in the coming years. It will reach a value of $5.32 billion by 2029, with a compound annual growth rate (CAGR) of 11.2%. This growth through the forecast period can be linked to increasing education and consciousness, the advent of monoclonal antibodies, a heightened focus on pediatric migraines, and the expansion of non-pharmaceutical interventions, as well as global efforts toward migraine research. Key trends for this period include progress in therapeutic strategies, uses of wearable and digital therapeutic devices, the rise of telemedicine and virtual consultations, patient-oriented care models, the growth in the market for generic drugs, and oral CGRP inhibitors.
View the full report here:
https://www.thebusinessresearchcompany.com/report/migraine-treatment-global-market-report
What Are the Key Growth Drivers Fueling the Migraine Treatment Market Expansion?
The surge in the migraine treatment market can be accounted to the extended exposure to screens. When we talk about screen exposure, it refers to how much time a person spends with electronic screens like smartphones, tablets, computers, and televisions. This excessive exposure is mainly due to increased work from home, digital learning, digital entertainment, and the increased dependency on technology for maintaining social relationships. Migraine treatments control migraine symptoms that are induced or worsened by prolong screen exposure and this includes medication, changes in lifestyle, and proper ergonomic practices to reduce strain and prevent migraines. In May 2024, data from the UK-based Parliament health agency, the House of Commons Committee, stated that in the year 2021, the screen time for children had surged by 52% in 2022, revealing that about 25% of the young population displayed smartphone usage habits that correlate with behavioral addiction. This implies that the growth of the migraine treatment market is fueled by prolonged screen exposure.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8126&type=smp
What Are the Key Trends Driving Migraine Treatment Market Growth?
The primary trend gaining traction in the migraine treatment market is product innovation. Companies leading this market are incorporating novel developments like liquid formulations to retain their market standing. In January 2022, for example, BioDelivery Sciences International (BDSI), a pharmaceutical company from the U.S., unveiled Elyxyb (celecoxib oral solution) for the acute treatment of migraines in adults, irrespective of aura experience. Its liquid formulation ensures swift absorption in the small intestine, providing quicker relief than standard tablets. This is especially advantageous for individuals suffering from migraines who also experience nausea or vomiting, as they no longer have to wait for a pill to dissolve. Elyxyb stands as the first and only FDA-approved oral solution ready for use in treating migraines, presenting a more effective and tolerable solution for managing the sudden, severe pain that migraines entail.
How Is the Migraine Treatment Market Segmented?
The migraine treatment market covered in this report is segmented -
1) By Types: Episodic, Migraine With Aura, Chronic, Other Types
2) By Treatment: Acute Or Abortive Treatment, Preventive Or prophylactic Treatment, Non-Pharmacological Therapies And Devices
3) By End-User: Hospitals, Clinics, Homecare, Other End-users
Subsegments:
1) By Episodic: Frequent Episodic Migraine, Infrequent Episodic Migraine
2) By Migraine With Aura: Visual Aura, Sensory Aura, Speech Or Language Aura
3) By Chronic: Chronic Migraine Without Aura, Chronic Migraine With Aura
4) By Other Types: Hemiplegic Migraine, Retinal Migraine, Menstrual Migraine, Other Specific Types
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=8126&type=smp
Which Companies Are Leading the Charge in Migraine Treatment Market Innovation?
Major companies operating in the migraine treatment market are Pfizer Inc., Eli Lilly and Company, Amgen Inc., GlaxoSmithKline PLC, Novartis AG, Bayer AG, Allergan PLC, Abbott Laboratories, Allodynic Therapeutics LLC, AOBiome LLC, AstraZeneca PLC, Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, Dr. Reddy's Laboratories Limited, Impel Pharmaceuticals Inc., AbbVie Inc., Alder BioPharmaceuticals Inc., Astellas Pharma Inc., Biohaven Pharmaceutical Holding Company Ltd., Bristol-Myers Squibb Company, Daiichi Sankyo Company Limited, Eisai Co. Ltd., Endo International PLC, Impax Laboratories Inc., Johnson & Johnson Inc., Lannett Company Inc., Lupin Limited, Merck & Co. Inc., Mylan N.V.
Which Regions Are Leading the Global Migraine Treatment Market in Revenue?
North America was the largest region in the migraine treatment market in 2024. The regions covered in the migraine treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8126
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Migraine Treatment Market: Major Trends Reshaping the Future of the Industry here
News-ID: 4084174 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Migraine
Leading Growth Driver in the Migraine Market Share in 2025: Rising Prevalence Of …
What Market Share dynamics are playing a key role in accelerating the growth of the migraine Market Share?
The migraine Market Share is projected to grow, driven by the rising occurrence of migraines. Migraines, a kind of headache that typically affects one side of the brain and causes intense, throbbing pain or a pulsing sensation, can be managed and relief can be provided via proper treatment. This treatment paves the way…
Emerging Acute Migraine Treatment Market Trend 2025-2034: Innovative CGRP Recept …
How Is the Acute Migraine Treatment Market Projected to Grow, and What Is Its Market Size?
The market size for acute migraine treatment has witnessed substantial growth in the past few years. Forecasts expect it to expand from $2.6 billion in 2024 to $2.91 billion in 2025, boasting a compound annual growth rate (CAGR) of 11.6%. Factors contributing to this growth in the historical period include the rising incidence of migraines,…
Key Influencer in the Migraine Market 2025: Rising Prevalence Of Migraine Drives …
"What Is the Forecasted Market Size and Growth Rate for the Migraine Market?
The migraine market is projected to grow steadily from $1.93 billion in 2024 to $1.97 billion in 2025, at a CAGR of 2.2%. This growth is attributed to the rising prevalence of migraines, growing awareness of treatment options, government initiatives, increased alcohol consumption, and lifestyle changes.
Migraine Market: Expected to grow to $2.25 billion by 2029 at a CAGR…
How Big is Migraine Drugs Market?
In 2022, the Global Migraine Drugs Market soared to USD 10,972.1 million, marking a significant milestone. Projections indicate a promising trajectory, with expectations set for substantial growth, potentially reaching USD 26,618.96 million by 2031. Forecasts for the period between 2024 and 2031 suggest a robust Compound Annual Growth Rate (CAGR) of 12.1% for the migraine drugs market.
The objectives outlined in the report are multifaceted and aimed at offering a comprehensive…
Migraine Therapeutics Market - Relieve the Burden: Empowering Lives through Migr …
Newark, New Castle, USA - new report, titled Migraine Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Migraine Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Migraine Therapeutics market. The report offers an overview of the market, which…
Rise in Prevalence of Migraine Drives the Migraine Drugs Market | Outlook 2025
Migraine is characterized by a recurrent throbbing headache, which affects only one side of the head. It is accompanied by vomiting, nausea and even altered vision in some cases.
The increase in the prevalence of migraine, the rapid increase in the female population and the increased awareness among patients for the treatment and prevention of migraine are driving the growth of the global market for anti-migraine drugs.
Get Access to TOC /…
